Biopure’s Hemopure BPAC Review To Be Closed-Door
This article was originally published in The Pink Sheet Daily
Executive Summary
The day before Biopure's July 14 review, FDA's Blood Products Advisory Committee will discuss Nabi's Nabi-HB immunoglobulin for hepatitis B.